Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
23 Oct 2019 Number of Deaths, Incident Cases, and Disability-Adjusted Life-Years Caused by Pancreatic Cancer Has More Than Doubled From 1990 To 2017 Gastrointestinal cancers - Epidemiology/Etiology/Cancer Prevention
22 Oct 2019 EMA Recommends Refusal of the Marketing Authorisation for Quizartinib Haematologic malignancies - Personalised medicine - Anticancer agents & Biologic therapy
21 Oct 2019 EMA Recommends Extension of Indications for Daratumumab Haematologic malignancies - Anticancer agents & Biologic therapy
18 Oct 2019 EMA Recommends Extension of Indications for Pembrolizumab Head and neck cancers - Cancer Immunology and Immunotherapy
17 Oct 2019 Social Outcomes after Adolescent and Young Adult Cancer Cancer in Special Situations / Population
10 Oct 2019 The Nobel Prize in Physiology or Medicine 2019 Basic science - Translational research
09 Oct 2019 Four-Week Limit for Use of High-Strength Oestradiol Creams Epidemiology/Etiology/Cancer Prevention
08 Oct 2019 How To Ensure That Novel Analytic Methods Are Fit for Decision-Making Bioethics, legal and economic issues
04 Oct 2019 FDA Approves Daratumumab for Transplant-Eligible Multiple Myeloma Haematologic malignancies - Anticancer agents & Biologic therapy
03 Oct 2019 EMA Recommends Extension of Indications for Taxotere and Docetaxel Zentiva Genitourinary cancers - Anticancer agents & Biologic therapy
30 Sep 2019 Adding Atezolizumab to Front-Line Platinum-Based Chemotherapy Improves Progression-Free Survival in mUC Genitourinary cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
30 Sep 2019 Olaparib Outperforms Enzalutamide or Abiraterone Acetate in Men with mCRPC and HRR Alterations Genitourinary cancers - Personalised medicine - Anticancer agents & Biologic therapy
30 Sep 2019 Ivosidenib Provides Prolonged Progression-Free Survival in Patients with Cholangiocarcinoma and IDH1 Mutation Gastrointestinal cancers - Personalised medicine - Anticancer agents & Biologic therapy
30 Sep 2019 Efficacy Differences Are Observed According to Patients’ Sex with Immunotherapy in Advanced Solid Tumours Cancer Immunology and Immunotherapy
30 Sep 2019 First Report of Head and Neck Squamous Cell Carcinoma Treatment Individualised by Geriatric Assessment Head and neck cancers - Cancer in Special Situations / Population